Figure 1.

Xenobiotic metabolizing enzyme polymorphisms and risk of ESCC. Heterozygote and homozygote variant alleles were combined for each gene and wild type was used as reference. The middle dot of each line represents an odds ratios value, the left and the right dot of each line represent the lower and upper limits of 95% confidence interval, respectively. (a) Phase I and phase II enzyme polymorphisms and risk of ESCC among the study subjects. (b) Phase I and phase II enzyme polymorphisms and risk of ESCC in male subjects. (c) Phase I and phase II enzyme polymorphisms and risk of ESCC in female subjects.